Answers are grounded in this paper and cite their sources.
The da Vinci SP robotic surgical system received regulatory approval for use in colorectal cancer surgery in Japan in April 2023. Given the advantages of the precision of a robot and the postoperative cosmesis of single-site surgery, the system is expected to be further utilized for minimally invasive surgeries, in addition to the curative and safety-assured laparoscopic technique.
No takes yet. Share an insight, caveat, or question.
Noda et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: